NASD · Healthcare · Drug Manufacturers - Specialty & Generic · USA
Viatris Inc is a large cap company (market value between $10 billion and $200 billion) in the Drug Manufacturers - Specialty & Generic industry.
Viatris is a healthcare company distributing medicines across multiple therapeutic areas to patients in numerous countries. The company reaches customers through various channels including pharmacies, wholesalers, government entities, hospitals, and healthcare providers. Its product portfolio encompasses generic medications, recognized brands, and innovative pharmaceutical treatments.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Viatris Inc stock.
Not valued: We cannot value this company yet.
We do not publish a value for this company: a figure this valuation depends on is missing.
Leak Score: 45/100 on 9 of 12 signals (On Watch).
17 more funds hold it; the full list is part of the paid plan.
All 84 Drug Manufacturers - Specialty & Generic stocks
34 more in this industry show a wider margin of safety.
We do not publish a verdict on VTRS yet. We are missing a figure this valuation depends on. We would rather say so than show a number built on a guess.
We do not publish one (as of the 2026-10-19 close). We are missing a figure this valuation depends on. We would rather say so than show a number built on a guess.
45 out of 100, which we rate "On Watch", on 9 of 12 value investing signals.